Nephrolithiasis: Clinical Trials

29 trials for Nephrolithiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed. 29 Phase 2, 6 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 229Completed 29
Phase 16Completed 6
Phase 34Completed 4

Follow Nephrolithiasis: new trials by email Literature Review of Nephrolithiasis trials Research Report on Nephrolithiasis

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones
LLX-424 - Kidney Stones
Phase 2CompletedLilac Therapeutics, Inc.512025-03-232025-10-29
Flexible Mini Percutaneous Nephrolithotomy Vs Retrograde Intra-renal Surgery
flexible mini percutaneous nephrolithotomy, Retrograde intrarenal surgery - Renal Stone
Phase 2 / Phase 3CompletedAin Shams University1302024-01-012024-10-29
Erector Spinae Plane Block for Uncomplicated Renal Colic
Erector Spinae Plane Block (ESPB), Ropivacaine - Renal Colic, Kidney Stone
Phase 2CompletedUniversity of Michigan52023-02-082025-10-30
Silodosin in Management of Lower Ureteral Stones
Silodosin - Stone, Kidney
Phase 1 / Phase 2CompletedSyrian Private University1002022-10-202024-04-24
Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers
Empagliflozin 25 MG, Placebo - Kidney Stone
Phase 2CompletedInsel Gruppe AG, University Hospital Bern502021-08-252023-05-12
Effect of Antihistamines on Ureteral Stent-Related Symptoms
Fexofenadine Hcl 180Mg Tab, Placebo - Nephrolithiasis
Phase 2CompletedColumbia University782021-06-292025-07-16
Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels
Fluconazole, Placebo - Nephrolithiasis, Nephrocalcinosis
Phase 2CompletedHospices Civils de Lyon562021-01-132024-07-12
Perioperative Pregabalin in Ureteroscopy
Pregabalin 300mg, Placebo oral tablet - Kidney Stone, Pain, Postoperative
Phase 2 / Phase 3CompletedUniversity of Missouri-Columbia1182020-06-012025-11-12
Pramipexole and Morphine for Renal Colic
Pramipexole, Morphine, Placebo oral tablet - Renal Colic
Phase 1 / Phase 2CompletedEast Carolina University192019-10-282023-03-08
Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract
Renalof, Placebo - Renal Injury, Kidney Injury
Phase 2CompletedCatalysis SL1552019-08-012021-01-06
Supine Percutaneous Nephrolithotomy
percutaneous nephrolithotomy (supine position), percutaneous nephrolithotomy ( prone position) - Renal Stone
Phase 2 / Phase 3CompletedAin Shams University702019-06-012022-07-14
Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia
ALLN-177 - Enteric Hyperoxaluria, Primary Hyperoxaluria
Phase 2CompletedAllena Pharmaceuticals152018-07-172020-12-30
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
Ketorolac, normal saline - Pain, Urinary Stone
Phase 2CompletedUniversity of Texas Southwestern Medical Center1252018-06-282024-01-10
Toradol to Reduce Ureteroscopic Symptoms Trial
Toradol - Urinary Lithiasis, Kidney Diseases
Phase 2CompletedYale University942017-08-012021-11-02
Lipoic Acid Supplement for Cystine Stone
Alpha lipoic acid, Placebo - Cystinuria
Phase 2CompletedThomas Chi, MD502017-06-192026-04-15
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
ALLN-177, Placebo - Secondary Hyperoxaluria, Nephrolithiasis
Phase 2CompletedAllena Pharmaceuticals662015-09-012017-01-19
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones
ALLN-177 low dose, ALLN-177 mid dose, ALLN-177 high dose - Secondary Hyperoxaluria, Nephrolithiasis
Phase 2CompletedAllena Pharmaceuticals322015-07-012018-01-11
Comparing Pneumatic Versus Ultra-sonic Percutaneous Nephrolithotomy in Large Kidney Stones
Pneumatic percutaneous nephrolithotomy, Ultra-sonic percutaneous nephrolithotomy - Kidney Stone
Phase 2CompletedIsfahan University of Medical Sciences1802014-12-012016-04-26
Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
ALLN-177 - Hyperoxaluria, Nephrolithiasis
Phase 2CompletedAllena Pharmaceuticals162014-09-012019-06-05
Treatment for Calcium Phosphate Kidney Stone Disease
Placebo, Citric Acid, Potassium Citrate - Calcium Phosphate Kidney Stones
Phase 2CompletedUniversity of Texas Southwestern Medical Center132012-07-012024-04-04

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Kidney Calculi (24)  ·  Kidney Diseases (5)  ·  Urolithiasis (5)  ·  Hyperoxaluria (4)  ·  Renal Colic (3)  ·  Urologic Diseases (3)  ·  Calculi (2)  ·  Cystinuria (2)  ·  Hypercalciuria (2)  ·  Nephrolithiasis, Calcium Oxalate (2)  ·  Pain, Postoperative (2)  ·  Ureteral Calculi (2)  ·  Ureteral Obstruction (2)  ·  Urinary Calculi (2)

Broader conditions

Female Urogenital Diseases (29)  ·  Female Urogenital Diseases and Pregnancy Complications (29)  ·  Male Urogenital Diseases (29)  ·  Urogenital Diseases (29)  ·  Urologic Diseases (26)  ·  Pathological Conditions, Signs and Symptoms (25)  ·  Kidney Diseases (24)  ·  Pathological Conditions, Anatomical (24)  ·  Urolithiasis (24)  ·  Calculi (22)  ·  Urinary Calculi (22)  ·  Signs and Symptoms (8)  ·  Neurologic Manifestations (6)  ·  Pain (5)

Interventions

oxalate decarboxylase (4)  ·  reloxaliase (4)  ·  Ketorolac Tromethamine (2)  ·  silodosin (2)  ·  Allopurinol (1)  ·  Citric Acid (1)  ·  Febuxostat (1)  ·  Fluconazole (1)  ·  Isoproterenol (1)  ·  Ketorolac (1)  ·  Morphine (1)  ·  Nephrolithotomy, Percutaneous (1)  ·  Potassium Citrate (1)  ·  Pramipexole (1)  ·  Pregabalin (1)

Sponsors

Allena Pharmaceuticals (4)  ·  Ain Shams University (2)  ·  Mayo Clinic (2)  ·  University of Texas Southwestern Medical Center (2)  ·  Catalysis SL (1)  ·  Columbia University (1)  ·  East Carolina University (1)  ·  Fredericia Hosptial (1)  ·  Hospices Civils de Lyon (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Isfahan University of Medical Sciences (1)  ·  Lilac Therapeutics, Inc. (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Mario Negri Institute for Pharmacological Research (1)  ·  Omeros Corporation (1)

Countries

United States (18)  ·  Egypt (2)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Iran (1)  ·  Italy (1)  ·  Nicaragua (1)  ·  Switzerland (1)  ·  Syria (1)  ·  United Kingdom (1)

Top investigators

Annamaria Kausz, MD MS (2)  ·  Chris Fung (1)  ·  Daniel Fuster, MD (1)  ·  David Clark, MD (1)  ·  Jamshid Roozbeh, MD (1)  ·  John C Lieske, MD (1)  ·  John D Denstedt, MD, FRCSC (1)  ·  Katie Murray, DO (1)  ·  Kori Brewer, PhD (1)  ·  Lee Brettman, MD, FACP (1)  ·  Margaret Pearle, MD.PhD (1)  ·  Naim M Maalouf, MD (1)  ·  Nasser Simforoosh, Prof (1)  ·  Ojas Shah, MD (1)

Results publications

PMID 20736987, PMID 21161651, PMID 21419606, PMID 23929928, PMID 30783888, PMID 34569278, PMID 35288397, PMID 35710560, PMID 39411383, PMID 39747681, PMID 39937815

NIH funding

P50DK083007 (2), 2017 (1), P20DK100863 (1), R21AT002534 (1), R21DK097476 (1), UL1RR024150 (1)